Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA222965-05
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression
National Institutes of Health
Grant: 5R35NS105068-05
Preclinical development of breakthrough immunotherapy for brain tumors
NCI NIH HHS
Grant: R01 CA222965
NINDS NIH HHS
Grant: R35 NS105068
NCI NIH HHS
Grant: T32 CA151022
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals